Workflow
招商证券A股中报解读:收入端边际改善 关注中游制造业、医药生物业绩的回暖
Zhi Tong Cai Jing·2025-09-01 22:44

Core Viewpoint - The overall profitability growth of A-share listed companies is slowing down due to continuous price declines and weak effective demand, despite some improvements in revenue [1][2] Profitability Analysis - The net profit growth of listed companies has narrowed, with quarterly net profit growth rates for 2024Q4, 2025Q1, and 2025Q2 being -15.7%, 3.2%, and 1.2% respectively [2] - Non-financial oil and petrochemical sectors show even more significant declines, with quarterly net profit growth rates of -50.2%, 4.5%, and -0.1% for the same periods [2] Revenue Trends - A-share companies have seen an improvement in quarterly revenue growth compared to 2025Q1, with growth rates of 1.4%, -0.3%, and 0.4% for 2024Q4, 2025Q1, and 2025Q2 respectively [2] - Non-financial oil and petrochemical sectors also show improved revenue growth rates of 1.2%, 0.5%, and 0.9% for the same quarters [2] Sector Performance - Key sectors showing improved profitability include healthcare, midstream manufacturing, and financial real estate, with information technology leading in profit growth [4] - The quarterly profit growth rates for 2025Q2 are ranked as follows: Information Technology > Midstream Manufacturing > Financial Real Estate > Healthcare > Utilities > Consumer Services > Resource Products [4] Cash Flow and Capital Expansion - Free cash flow as a percentage of market value and revenue is steadily increasing, with operating cash flow showing high growth, particularly from midstream manufacturing [5] - Capital expenditure growth has declined since reaching a peak in Q2 2023, with limited recovery in demand and low corporate capital expansion willingness [5] Focus Areas for Growth - Industries with high or improving profit growth in 2025Q2 include TMT (software development, gaming, components, communication devices, other electronics, semiconductors, consumer electronics), mid-to-high-end manufacturing, and certain resource products [6]